ANKYLOSING SPONDYLITIS (AS)
Clinical trials for ANKYLOSING SPONDYLITIS (AS) explained in plain language.
Never miss a new study
Get alerted when new ANKYLOSING SPONDYLITIS (AS) trials appear
Sign up with your email to follow new studies for ANKYLOSING SPONDYLITIS (AS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-world study confirms upadacitinib's safety in thousands of korean patients
Disease control CompletedThis study looked at the safety and effectiveness of upadacitinib, a drug already approved for rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, and psoriatic arthritis. About 2,369 Korean adults took the drug as prescribed by their doctor and were followed for 28 …
Matched conditions: ANKYLOSING SPONDYLITIS (AS)
Sponsor: AbbVie • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Scientists probe immune receptor in ankylosing spondylitis blood samples
Knowledge-focused CompletedThis study looked at blood samples from 24 people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine) and 12 healthy volunteers. Researchers measured immune cells and tested whether a lab-made antibody called IPH4102 could reduce inflammation. No t…
Matched conditions: ANKYLOSING SPONDYLITIS (AS)
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 17, 2026 00:28 UTC
-
Tiny study tracks sleep and steps in ankylosing spondylitis patients
Knowledge-focused CompletedThis study followed 18 adults with active ankylosing spondylitis (a type of arthritis affecting the spine) to see how their sleep and physical activity changed after starting a new medication. Participants wore activity monitors and had overnight sleep tests at the start and agai…
Matched conditions: ANKYLOSING SPONDYLITIS (AS)
Sponsor: Samsun University • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC